OxThera
OxThera develops products for the treatment of metabolic disorders resulting from excess levels of oxalate.
OxThera has raised €74M across 4 funding rounds from 6 investors, most recently a round in Nov 2016. Based in Stockholm, Sweden; founded 2007; active in Healthtech. Data as of 28 Oct 2026.
Total raised
€74M
€74,350,000
Funding rounds
4
Investors
6
distinct backers
Active since
2005-07
latest 2016-11
Funding by year
EUR raised per yearOxThera — funding by year — interactive chart.
Data table
| OxThera — funding by year | |
|---|---|
| 2005 | €18M |
| 2007 | €17M |
| 2014 | €7.7M |
| 2016 | €32M |
Signals
High confidenceRaise-next likelihood7
base rate 30% for Other
- ▼ Dormant (no round in 3+ cohort gaps)
- ▲ Up-round momentum
Exit likelihood8
base rate 11% (2+ rounds)
- ▲ €30M+ raised
- ▲ 4 rounds raised
- ▼ Old (19y) — past typical exit age
- ▼ No recent equity round (debt-only or quiet)
Timing: dormant vs cohort gap · momentum up. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
4 rounds| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2016-11-01 | Other | €32M | Industrifonden,LSP,Sunstone Capital,Ysios Capital | View deal → |
| 2014-04-01 | Other | €7.7M | IDInvest Partners | View deal → |
| 2007-06-01 | Other | €17M | HealthCap | View deal → |
| 2005-07-01 | Other | €18M | HealthCap | View deal → |
Similar companies
same sector or countryGlobal coverage: FundingData